BIOMAT Database Logo BIOMAT Database Logo

CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. 1998

R D Berkowitz, and S Alexander, and C Bare, and V Linquist-Stepps, and M Bogan, and M E Moreno, and L Gibson, and E D Wieder, and J Kosek, and C A Stoddart, and J M McCune
Gladstone Institute of Virology and Immunology, San Francisco, Stanford University, Stanford, and Veterans Hospital, Palo Alto, California, USA.

CCR5-utilizing (R5) and CXCR4-utilizing (X4) strains of human immunodeficiency virus type 1 (HIV-1) have been studied intensively in vitro, but the pathologic correlates of such differential tropism in vivo remain incompletely defined. In this study, X4 and R5 strains of HIV-1 were compared for tropism and pathogenesis in SCID-hu Thy/Liv mice, an in vivo model of human thymopoiesis. The X4 strain NL4-3 replicates quickly and extensively in thymocytes in the cortex and medulla, causing significant depletion. In contrast, the R5 strain Ba-L initially infects stromal cells including macrophages in the thymic medulla, without any obvious pathologic consequence. After a period of 3 to 4 weeks, Ba-L infection slowly spreads through the thymocyte populations, occasionally culminating in thymocyte depletion after week 6 of infection. During the entire time of infection, Ba-L did not mutate into variants capable of utilizing CXCR4. Therefore, X4 strains are highly cytopathic after infection of the human thymus. In contrast, infection with R5 strains of HIV-1 can result in a two-phase process in vivo, involving apparently nonpathogenic replication in medullary stromal cells followed by cytopathic replication in thymocytes.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013950 Thymus Gland A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat. Thymus,Gland, Thymus,Glands, Thymus,Thymus Glands
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

R D Berkowitz, and S Alexander, and C Bare, and V Linquist-Stepps, and M Bogan, and M E Moreno, and L Gibson, and E D Wieder, and J Kosek, and C A Stoddart, and J M McCune
Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.
September 2005, Journal of virology,
R D Berkowitz, and S Alexander, and C Bare, and V Linquist-Stepps, and M Bogan, and M E Moreno, and L Gibson, and E D Wieder, and J Kosek, and C A Stoddart, and J M McCune
Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo.
April 1992, Journal of virology,
R D Berkowitz, and S Alexander, and C Bare, and V Linquist-Stepps, and M Bogan, and M E Moreno, and L Gibson, and E D Wieder, and J Kosek, and C A Stoddart, and J M McCune
The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection.
January 2004, AIDS research and human retroviruses,
R D Berkowitz, and S Alexander, and C Bare, and V Linquist-Stepps, and M Bogan, and M E Moreno, and L Gibson, and E D Wieder, and J Kosek, and C A Stoddart, and J M McCune
Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy.
January 2006, Journal of virology,
R D Berkowitz, and S Alexander, and C Bare, and V Linquist-Stepps, and M Bogan, and M E Moreno, and L Gibson, and E D Wieder, and J Kosek, and C A Stoddart, and J M McCune
In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5.
June 1998, Journal of virology,
R D Berkowitz, and S Alexander, and C Bare, and V Linquist-Stepps, and M Bogan, and M E Moreno, and L Gibson, and E D Wieder, and J Kosek, and C A Stoddart, and J M McCune
Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates.
August 2001, Journal of virology,
R D Berkowitz, and S Alexander, and C Bare, and V Linquist-Stepps, and M Bogan, and M E Moreno, and L Gibson, and E D Wieder, and J Kosek, and C A Stoddart, and J M McCune
Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo.
September 1999, Journal of virology,
R D Berkowitz, and S Alexander, and C Bare, and V Linquist-Stepps, and M Bogan, and M E Moreno, and L Gibson, and E D Wieder, and J Kosek, and C A Stoddart, and J M McCune
Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.
March 2006, Virology,
R D Berkowitz, and S Alexander, and C Bare, and V Linquist-Stepps, and M Bogan, and M E Moreno, and L Gibson, and E D Wieder, and J Kosek, and C A Stoddart, and J M McCune
CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates.
March 2002, Journal of virology,
R D Berkowitz, and S Alexander, and C Bare, and V Linquist-Stepps, and M Bogan, and M E Moreno, and L Gibson, and E D Wieder, and J Kosek, and C A Stoddart, and J M McCune
CXCR4 or CCR5 tropism of human immunodeficiency virus type 1 isolates does not determine the immunological milieu in patients responding to antiretroviral therapy.
January 2006, Viral immunology,
Copied contents to your clipboard!